Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded new trial locations and local institutions (e.g., Florianópolis, Salvador, Viedma) with investigator contacts, and removed several existing sites; total locations updated to 764.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded new study sites in Krefeld (Germany), Valledupar (Colombia), Floridablanca (Colombia), Bogotá (Colombia), and Buenos Aires (Argentina), updated site contacts, and increased total locations to 761. Montpellier-related entries and other site records were removed or corrected as part of data cleanup.SummaryDifference0.2%

- Check45 days agoChange DetectedAdded site 007-436 in Pergamino, Argentina (B2700KMP) and updated contact details for Eva-Lotte Buchmeier (site 2217) and Ullrich Graeven (site 2221). The total number of locations is now 756.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Instituto de Oncologia de Rosario (Site 007-5004) with Lucas Lucchesi Bosco; removed Sang-We Kim (Site 007-104). Updated the email line requirement to include NCT # and Site #, and added IPD sharing information with the provided URL and Revision: v3.4.1.SummaryDifference0.1%

- Check66 days agoChange DetectedStudy locations increased to 755 with new sites and contacts added, and certain contacts were removed or updated.SummaryDifference0.1%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.